Redox-active nuisance screening compounds and their classification

Drug Discovery Today

Volumn 16, Issue 17-18, 2011, Pages 840-841

  Baell, Jonathan B ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DITHIOTHREITOL; GLUTATHIONE; MERCAPTOETHANOL; NITRILE; SULFONE; TRIS(2 CARBOXYETHYL)PHOSPHINE;

BIOASSAY; CHEMISTRY; NOTE; OXIDATION REDUCTION REACTION; SUBSTITUTION REACTION;

EID: 80052846086     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.06.011     Document Type: Short Survey

References (23)

1. R.W. Spencer High-throughput screening of historic collections: observations on file size, biological targets, and file diversity Biotechnol. Bioeng. 61 1998 61 67 (Pubitemid 28561945)
2. O. Roche Development of a virtual screening method for identification of "frequent hitters" in compound libraries J. Med. Chem. 45 2002 137 1420
3. S.L. McGovern A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J. Med. Chem. 45 2002 1712 1722 (Pubitemid 34293537)
4. J.R. Huth ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens J. Am. Chem. Soc. 127 2005 217 224 (Pubitemid 40094385)
5. B. Pearce An empirical process for the design of high-throughput screening deck filters J. Chem. Inf. Model. 46 2006 1060 1068 (Pubitemid 43999150)
6. D.R. Goode Identification of promiscuous small molecule activators in high-throughput enzyme activation screens J. Med. Chem. 51 2008 2346 2349 (Pubitemid 351628495)
7. A. Simeonov Fluorescence spectroscopic profiling of compound libraries J. Med. Chem. 51 2008 2363 2371 (Pubitemid 351628498)
8. D.S. Auld Characterization of chemical libraries for luciferase inhibitory activity J. Med. Chem. 51 2008 2372 2386 (Pubitemid 351628499)
9. A. Jadhav Quantitative analyses of aggregation, autofluorescence, and reactivity artefacts in a screen for inhibitors of a thiol protease J. Med. Chem. 53 2010 37 51
10. N. Thorne Apparent activity in high-throughput screening: origins of compound-dependent assay interference Curr. Opin. Chem. Biol. 14 2010 315 324
11. R. Sink False positives in the early stages of drug discovery Curr. Med. Chem. 17 2010 4231 4255
12. 2 in HTS buffers containing strong reducing reagents-real hits or promiscuous artifacts? Curr. Opin. Chem. Biol. 15 2011 174 182
13. J.B. Baell, and G.A. Holloway New substructure filters for removal of pan assay interference compounds [PAINS] from screening libraries and for their exclusion in bioassays J. Med. Chem. 53 2010 2719 2740
14. J.B. Baell Observations on screening-based research and some concerning trends in the literature Future Med. Chem. 2 2010 1529 1546
15. L. Lor A simple assay for detection of small-molecule redox activity J. Biomol. Screen. 12 2007 881 890 (Pubitemid 47340702)
16. P.A. Johnston Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents Assay Drug Dev. Technol. 6 2008 505 518
17. A. Rusinko 3rd Analysis of a large structure/biological activity data set using recursive partitioning J. Chem. Inf. Comput. Sci. 39 1999 1017 1026
18. A.M.M. Jorgensen Structural diversity of small molecule libraries J. Chem. Inf. Comput. Sci. 41 2001 338 345 (Pubitemid 32408648)
19. D.M. Schnur Are target-family-privileged substructures truly privileged? J. Med. Chem. 49 2006 2000 2009
20. A.A. Shelat, and R.K. Guy Scaffold composition and biological relevance of screening libraries Nat. Chem. Biol. 3 2007 442 446 (Pubitemid 47080378)
21. L.B. Akella, and D. DeCaprio Cheminformatics approaches to analyze diversity in compounds screening libraries Curr. Opin. Chem. Biol. 14 2010 325 330
22. S.W. Muchmore Cheminformatics tools for medicinal chemists J. Med. Chem. 53 2010 4830 4841
23. R. Hariharan MultiMCS: a fast algorithm for the maximum common substructure problem on multiple molecules J. Chem. Inf. Model. 51 2011 788 806